[HTML][HTML] Current status and future direction of metallic and polymeric materials for advanced vascular stents

SH Im, DH Im, SJ Park, Y Jung, DH Kim… - Progress in Materials …, 2022 - Elsevier
Cardiovascular disease (CVD) has emerged as a severe illness worldwide. Currently, the
top ten causes of death in the world include ischemic heart disease according to the Global …

Diretriz da Sociedade Brasileira de Cardiologia e da Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista sobre intervenção coronária percutânea

F Feres, RA Costa, D Siqueira, JR Costa Jr… - Arquivos brasileiros de …, 2017 - SciELO Brasil
A Cardiologia Intervencionista tem experimentado extraordinário avanço nos últimos anos,
sendo atualmente o método de revascularização do miocárdio mais empregado em todos …

Rectifying disorder of extracellular matrix to suppress urethral stricture by protein nanofilm-controlled drug delivery from urinary catheter

J Tian, D Fu, Y Liu, Y Guan, S Miao, Y Xue… - Nature …, 2023 - nature.com
Urethral stricture secondary to urethral injury, afflicting both patients and urologists, is
initiated by excessive deposition of extracellular matrix in the submucosal and periurethral …

Controlled slow-release drug-eluting stents for the prevention of coronary restenosis: recent progress and future prospects

T Hu, J Yang, K Cui, Q Rao, T Yin, L Tan… - … applied materials & …, 2015 - ACS Publications
Drug-eluting stents (DES) have become more widely used by cardiologists than bare metal
stents (BMS) because of their better ability to control restenosis. However, recognized …

Current state of bioabsorbable polymer-coated drug-eluting stents

A Akinapelli, JP Chen, K Roy… - Current cardiology …, 2017 - ingentaconnect.com
Drug-eluting stents (DES) have been shown to significantly reduce clinical and angiographic
restenosis compared to bare metal stents (BMS). The polymer coatings on DES elute …

Clinical outcomes in 995 unselected real-world patients treated with an ultrathin biodegradable polymer-coated sirolimus-eluting stent: 12-month results from the …

PA Lemos, P Chandwani, S Saxena… - BMJ open, 2016 - bmjopen.bmj.com
Objectives To evaluate, in the FLEX Registry, clinical outcomes of an ultrathin (60 µm)
biodegradable polymer-coated Supraflex sirolimus-eluting stent (SES) for the treatment of …

Efficacy and Safety of TiNO-Coated Stents versus Drug-Eluting Stents in Acute Coronary Syndrome: Systematic Literature Review and Meta-Analysis

FC Daoud, L Létinier, N Moore, P Coste… - Biomedicines, 2022 - mdpi.com
(1) Background: Practice guidelines define drug-eluting stents (DES) as the standard of care
in coronary percutaneous coronary intervention (PCI), including in acute coronary syndrome …

A systematic review and meta-analysis of bioresorbable vascular scaffolds for below-the-knee arterial disease

J Ipema, S Kum, E Huizing, MA Schreve… - International …, 2021 - research.rug.nl
INTRODUCTION: Different types of bioresorbable vascular scaffolds (BVSs) have been
developed and used in below-the-knee (BTK) arterial diseases. This is the first study …

Metallic Limus‐Eluting Stents Abluminally Coated with Biodegradable Polymers: Angiographic and Clinical Comparison of a Novel Ultra‐Thin Sirolimus Stent Versus …

PA Lemos, AAC Abizaid, GC Meireles… - Cardiovascular …, 2015 - Wiley Online Library
Aims To evaluate the outcomes of patients treated with a new drug‐eluting stent formulation
with low doses of sirolimus, built in an ultra‐thin‐strut platform coated with biodegradable …

Five-Year Efficacy and Safety of TiNO-Coated Stents Versus Drug-Eluting Stents in Acute Coronary Syndrome: A Meta-Analysis

FC Daoud, B Catargi, PP Karjalainen… - Journal of clinical …, 2023 - mdpi.com
(1) Background: Percutaneous coronary interventions (PCI) in patients with acute coronary
syndrome (ACS) are performed with titanium-nitride-oxide-coated stents (TiNOSs) or drug …